Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Hearing Loss and Dizziness in Patients Receiving Oxaliplatin for Solid Tumors

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Case Comprehensive Cancer Center Identifier:
First received: March 21, 2006
Last updated: November 20, 2014
Last verified: November 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2014
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)